Biomarker Strategies Llc
CAGE Code: 4UPX8
NCAGE Code: 4UPX8
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 806256215
Summary
Biomarker Strategies Llc is an Active Commercial Supplier with the Cage Code 4UPX8 and is tracked by Dun & Bradstreet under DUNS Number 806256215..
Address
15601 Crabbs Branch Way
Derwood MD 20855-2734
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Atlantic Guns Inc Home Tech, Llc Ugis, Llc Hunt Graphics, Inc. Guardian Fire Protection Services, Network Spectrum Inc New Century Enterprise Group, Inc. Mercury Associates Inc Gerry Smith Office Products Inc Commercetran, Inc Shariat Fereydoun Gwen M Moulton Eagle 3Llc J M Pension Advisory Inc Ugolini, Patrick Advanced Integrated Environmental Contex Scanning Technology Inc R.B. Tec .Inc. Gala Engineering, Llc Cutting Corporation, The
Frequently Asked Questions (FAQ) for CAGE 4UPX8
- What is CAGE Code 4UPX8?
- 4UPX8 is the unique identifier used by NATO Organizations to reference the physical entity known as Biomarker Strategies Llc located at 15601 Crabbs Branch Way, Derwood MD 20855-2734, United States.
- Who is CAGE Code 4UPX8?
- 4UPX8 refers to Biomarker Strategies Llc located at 15601 Crabbs Branch Way, Derwood MD 20855-2734, United States.
- Where is CAGE Code 4UPX8 Located?
- CAGE Code 4UPX8 is located in Derwood, MD, USA.
Contracting History for CAGE 4UPX8 Most Recent 25 Records
- 75N91019C00022
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- 23 Mar 2023
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,027.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00022
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- 12 Sep 2019
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,027.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00022
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- 7 May 2021
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,027.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00022
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- 3 Mar 2021
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,027.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00022
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- 15 Aug 2023
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,345,018.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00022
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- 12 Mar 2020
- Sbir Topic 354: A Novel Predictive Test For Response To Combination Immunotherapies For Patients With Non-Small Cell Lung Cancer (Nsclc)
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,027.00
- Department Of Health And Human Services (Hhs)